Home/Filings/4/0002089301-25-000004
4//SEC Filing

Tardiff Daniel 4

Accession 0002089301-25-000004

CIK 0001736730other

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 5:42 PM ET

Size

5.6 KB

Accession

0002089301-25-000004

Insider Transaction Report

Form 4
Period: 2025-12-11
Tardiff Daniel
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-12-11+145,500145,500 total
    Exercise: $6.01Exp: 2035-12-10Common Stock (145,500 underlying)
Footnotes (1)
  • [F1]This option has a vesting start date of December 1, 2025 and vests as to one third (33.33%) of the shares subject to the option on the first anniversary of the vesting start date and as to the remaining shares in equal monthly installments over 24 months thereafter, subject to continued service.

Issuer

Camp4 Therapeutics Corp

CIK 0001736730

Entity typeother

Related Parties

1
  • filerCIK 0002089301

Filing Metadata

Form type
4
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 5:42 PM ET
Size
5.6 KB